Ignite Creation Date:
2024-05-05 @ 5:32 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00477776
Status:
COMPLETED
Last Update Posted:
2009-09-21
First Post:
2007-05-23
Brief Title:
Maxolon to Improve Breastmilk Supply in Diabetic Women a Randomised Controlled Trial
Sponsor:
National University Hospital Singapore
Organization:
National University Hospital Singapore
Study Overview
Official Title:
Metoclopramide to Improve Lactogenesis II in Diabetic Women a Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2009-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Maxalon
Brief Summary:
Early use of oral maxalon can hasten and improve the establishment of breastfeeding in diabetic mothers after preterm and term deliveries
Maxolon promotes breastfeeding by working on the central nervous system which increases the milk producing hormone prolactin which in turn helps to increase the milk supply for breastfeeding Successful early breastfeeding establishment is important for continued breastfeeding
Maxolon promotes breastfeeding by working on the central nervous system which increases the milk producing hormone prolactin which in turn helps to increase the milk supply for breastfeeding Successful early breastfeeding establishment is important for continued breastfeeding
Detailed Description:
The study aims to determine the breastfeeding initiation and duration rate of a cohort of pregnant women with gestational diabetesdiet-controlled and insulin dependent and pre-existing diabetes assess the impact of a post natally administered galactogogue metoclopramide on the milk volume production and timing of lactogenesis II in diabetic women on diet control and insulin and determine the prolactin response to lactation among diabetic women on diet control and insulin
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None